Novel approach to COVID-19 vaccine shows early promise

(© Image: Adobestock) - Early studies in mice show this potential vaccine could produce stronger and longer lasting immunity to fight against variants. A Western University team's novel approach to developing a COVID-19 vaccine shows promise in inducing a robust immune response, early data shows. Several COVID-19 vaccines have been licensed and used for nearly one year now to protect people from the virus. But as different variants emerge, inducing stronger and longer lasting immunity to protect vaccinated individuals becomes even more important. New findings on the efficacy of a vaccine strategy developed by Chil-Yong Kang, professor in the department of microbiology and immunology and a team at the Schulich School of Medicine & Dentistry, were recently published in PLOS Pathogens . Data from studies in pre-clinical mouse models found the vaccine developed at Western creates powerful antibodies against SAR-CoV-2, the virus that causes COVID-19. The results also show the vaccine in development has the possibility of producing stronger and longer lasting immunity to fight against many COVID-19 variants.